Saleem Ahmad,
Cort S. Madsen,
Philip D. Stein,
Evan Janovitz,
Christine Huang,
Khehyong Ngu,
Sharon Bisaha,
Lawrence J. Kennedy,
Bang-Chi Chen,
Rulin Zhao,
Doree Sitkoff,
Hossain Monshizadegan,
Xiaohong Yin,
Carol S. Ryan,
Rongan Zhang,
Mary Giancarli,
Eileen Bird,
Ming Chang,
Xing Chen,
Robert Setters,
Debra Search,
Shaobin Zhuang,
Van Nguyen-Tran,
Carolyn A. Cuff,
Thomas Harrity,
Celia J. Darienzo,
Tong Li,
Richard A. Reeves,
Michael A. Blanar,
Joel C. Barrish,
Robert Zahler,
Jeffrey A. Robl,
- (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential. Ahmad, S., Madsen, C.S., Stein, P.D., Janovitz, E., Huang, C., Ngu, K., Bisaha, S., Kennedy, L.J., Chen, B.C., Zhao, R., Sitkoff, D., Monshizadegan, H., Yin, X., Ryan, C.S., Zhang, R., Giancarli, M., Bird, E., Chang, M., Chen, X., Setters, R., Search, D., Zhuang, S., Nguyen-Tran, V., Cuff, C.A., Harrity, T., Darienzo, C.J., Li, T., Reeves, R.A., Blanar, M.A., Barrish, J.C., Zahler, R., Robl, J.A. J. Med. Chem. (2008)